Healthcare
NBGI buys Horizon Care
NBGI has acquired Midlands-based specialist childcare provider Horizon Care, in a transaction that also put aside capital for expansion in the near future.
Bowmark Capital on healthcare buyout spree
Bowmark Capital is to acquire specialist healthcare provider Hesley North for around ТЃ75m, according to reports.
Bowmark backs Care Fertility Group MBO
Bowmark Capital has backed the management buyout of UK fertility clinic Care Fertility Group in a deal said to be worth ТЃ60m.
Fondo Italiano backs General Medical Merate
Fondo Italiano di Investimento has injected €13m into radiology equipment producer General Medical Merate in exchange for a minority stake.
Industrifonden et al. invest SEK 70m in Bonesupport
Industrifonden, Healthcap and Lundbeckfond Ventures have led a second funding round worth SEK 70m for Swedish medical equipment company Bonesupport.
Industrifonden leads €11m round in Nuevolution
Industrifonden and existing investors have provided Danish biotech company Nuevolution with a DKK 80.5m (тЌ11m) round of funding.
VCs in $28m funding round for Oxford Immunotec
A pool of venture capital firms has backed a $28m funding round for Oxford Universityтs medical diagnostics spin-off Oxford Immunotec.
BGF invests £4.4m in Springfield Healthcare Group
Business Growth Fund (BGF) has injected a total of ТЃ4.4m into care provider Springfield Healthcare Group.
OMERS PE acquires Lifeways from August Equity
The private equity branch of Canadian pension fund OMERS has acquired British healthcare services provider Lifeways from August Equity.
Seventure leads $4.7m series-C round in ProTip
Seventure and existing investors have injected $4.7m in French medical devices company ProTip.
CDC Entreprises et al. in €6.3m round for Link Care Services
CDC Entreprises, Siparex and iSource have provided French healthcare services provider Link Care Services (LCS) with a €6.3m funding round.
Sunstone Capital backs Adenium Biotech
Sunstone Capital has invested DKK 11m in Danish biotechnology company Adenium Biotech.
Enterprise Ventures and PHD Equity Partners invest in Barber
Enterprise Ventures (EV) and PHD Equity Partners have invested ТЃ2.7m in the ТЃ4.4m all-equity buyout of British equipment supplier Barber.
Fondo Strategico backs Kedrion Biopharma
State-backed Fondo Strategico Italiano has invested €150m in Italian biopharmaceuticals company Kedrion Biopharma in exchange for an 18.7% stake.
HTGF invests in AudioCure Pharma
High-Tech Gründerfonds (HTGF) and business angel Dr Schumacher have provided German drugs candidate developer AudioCure Pharma with seed funding.
Gimv invests £5.7m in series-B round for Prosonix
Gimv has committed ТЃ5.7m to the second closing of a series-B financing round, now totalling ТЃ17.1m, for UK-based pharma Prosonix.
Bridgepoint mulls Aenova exit
Bridgepoint is reviewing options for its German vitamins and generic prescription drugs portfolio company Aenova, the GP has confirmed.
CBPE buys minority stake in IVF clinic
CBPE Capital has bought a minority stake in London-based Assisted Reproduction & Gynaecology Centre (ARGC).
Clessidra and Avista acquire Rottapharm
Clessidra Capital Partners and Avista Capital Partners have acquired a 50% stake in Italian drugmaker Rottapharm from the founding family in a deal that values the business at €1.7bn, according to reports.
HTGF et al. inject €4.3m into Algiax Pharmaceuticals
High-Tech Gründerfonds (HTGF), private investors and promotional bank KfW have provided German biotech company Algiax Pharmaceuticals with a €4.3m seed funding round.
HTGF backs €1.45m t-cell round
High-Tech Gründerfonds (HTGF) has joined a €1.45m round for regenerative therapies developer t-cell Europe GmbH.
Arkeon backs NOVACYT
French investor Arkeon Gestion has participated in a €1.5m funding round for Vélizy-based cytology company NOVACYT.
Nordic Capital et al. sell Nycomed spinoff Fougera for $1.5bn
Nordic Capital, DLJ Merchant Banking Partners (DLJMB), and Avista Capital Partners have sold US-based Nycomed spinoff Fougera to Swiss trade player Novartis for $1.525bn.
Doughty Hanson acquires Grupo Hospitalario Quirón
Doughty Hanson has agreed to acquire a stake of around 40% in Spanish hospital group Grupo Hospitalario Quirón from current owners the Cordón Muro family, who will retain the remaining shares.